Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trial

BACKGROUND: Ankylosing spondylitis (AS) impacts quality of life. We assessed patient-reported outcomes (PROs), pain, fatigue, health-related quality of life (HRQoL) and work productivity in a phase III trial of tofacitinib. METHODS: Adults with AS and with inadequate response/intolerance to ≥2 non-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarro-Compán, Victoria, Wei, James Cheng-­Chung, Van den Bosch, Filip, Magrey, Marina, Wang, Lisy, Fleishaker, Dona, Cappelleri, Joseph C, Wang, Cunshan, Wu, Joseph, Dina, Oluwaseyi, Fallon, Lara, Strand, Vibeke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Spondyloarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163535/
https://www.ncbi.nlm.nih.gov/pubmed/35654457
http://dx.doi.org/10.1136/rmdopen-2022-002253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163535/
https://www.ncbi.nlm.nih.gov/pubmed/35654457
http://dx.doi.org/10.1136/rmdopen-2022-002253

Ejemplares similares